CF
Cantor Fitzgerald Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
426
Acadia Pharmaceuticals
ACAD
$4.26B
|
SJ
Sarah James
| $25.26 | $42 |
66%
upside
| Overweight |
22 Aug ‘23
2 years ago |
|
427
PAVmed
PAVM
$9.77M
|
RO
Ross Osborn
| $0.4455 | $8.61 |
1,833%
upside
| Neutral |
18 Aug ‘23
2 years ago |
|
428
TherapeuticsMD
TXMD
$12.5M
|
LC
Louise Chen
| $1.08 | $5 |
363%
upside
| Neutral |
17 Aug ‘23
2 years ago |
|
429
Clene
CLNN
$60.2M
|
CD
Charles Duncan
| $6.03 | $80 |
1,227%
upside
| Overweight |
16 Aug ‘23
2 years ago |
|
430
VolitionRX
VNRX
$64.8M
|
KM
Kyle Mikson
| $0.6020 | $2 |
232%
upside
| Overweight |
16 Aug ‘23
2 years ago |
|
|
IRD
431
Opus Genetics, Inc. Common Stock
IRD
$76.1M
|
KK
Kristen Kluska
| $1.27 | $17 |
1,239%
upside
| Overweight |
14 Aug ‘23
2 years ago |
|
432
Equillium
EQ
$114M
|
EN
Emma Nealon
| $1.91 | $2.80 |
47%
upside
| Overweight |
14 Aug ‘23
2 years ago |
|
|
CRDL
433
Cardiol Therapeutics
CRDL
$91.3M
|
CD
Charles Duncan
| $1.09 | $3 |
175%
upside
| Overweight |
14 Aug ‘23
2 years ago |
|
434
DURECT Corp
DRRX
$59.3M
|
KK
Kristen Kluska
| $1.91 | $41 |
2,047%
upside
| Overweight |
10 Aug ‘23
2 years ago |
|
435
Lipocine
LPCN
$15.7M
|
JK
Jennifer Kim
| $2.89 | $33 |
1,042%
upside
| Overweight |
27 Jul ‘23
2 years ago |
|
|
GRRR
436
Gorilla Technology Group
GRRR
$392M
|
BK
Brett Knoblauch
| $17.30 | $48 |
177%
upside
| Overweight |
26 Jul ‘23
2 years ago |
|
437
Datadog
DDOG
$47.5B
|
JR
Jonathan Ruykhaver
| $136.08 | $100 |
27%
downside
| Overweight |
18 Jul ‘23
2 years ago |
|
438
Acumen Pharmaceuticals
ABOS
$87.2M
|
PS
Pete Stavropoulos
| $1.44 | $13 |
803%
upside
| Overweight |
17 Jul ‘23
2 years ago |
|
|
THTX
439
Theratechnologies
THTX
$150M
|
LC
Louis Chen
| $3.27 | $36 |
1,001%
upside
| Overweight |
13 Jul ‘23
2 years ago |
|
440
Verastem
VSTM
$663M
|
AY
Alethia Young
| $10.77 | $34 |
216%
upside
| Overweight |
6 Jul ‘23
2 years ago |
|
441
ECARX Holdings
ECX
$571M
|
DS
Derek Soderberg
| $1.54 | $10 |
549%
upside
| Overweight |
20 Jun ‘23
2 years ago |
|
442
Innoviz Technologies
INVZ
$317M
|
JC
Josh Cohen
| $1.58 | $7 |
343%
upside
| Overweight |
18 May ‘23
2 years ago |
|
443
ProQR Therapeutics
PRQR
$258M
|
JK
Jennifer Kim
| $2.45 | $4.50 |
84%
upside
| Overweight |
17 May ‘23
2 years ago |
|
444
Hecla Mining
HL
$6.04B
|
MK
Mike Kozak
| $9.02 | $5.75 |
36%
downside
| Hold |
12 May ‘23
2 years ago |
|
445
VYNE Therapeutics
VYNE
$7.62M
|
LC
Louise Chen
| $0.2992 | $9 |
2,908%
upside
| Overweight |
12 May ‘23
2 years ago |
|
446
Nextracker
NXT
$10.4B
|
AS
Andres Sheppard
| $70.12 | $44 |
37%
downside
| Overweight |
11 May ‘23
2 years ago |
|
447
Cloudflare
NET
$74.7B
|
JR
Jonathan Ruykhaver
| $214.43 | $50 |
77%
downside
| Neutral |
28 Apr ‘23
2 years ago |
|
448
TG Therapeutics
TGTX
$5.11B
|
PA
Prakhar Agrawal
| $32.21 | $24 |
25%
downside
| Overweight |
17 Apr ‘23
2 years ago |
|
449
CRISPR Therapeutics
CRSP
$4.99B
|
OB
Olivia Brayer
| $54.86 | $72 |
31%
upside
| Overweight |
13 Apr ‘23
2 years ago |
|
450
Fennec Pharmaceuticals
FENC
$250M
|
CRI
Charles Robertson II
| $9 | $16 |
78%
upside
| Overweight |
6 Apr ‘23
2 years ago |
|